Related Experiment Video
Updated: May 4, 2026
06:22
Optical Sectioning and Visualization of the Intervertebral Disc from Embryonic Development to Degeneration
Published on: July 8, 2021
2.0K
Microarray analysis of genes and gene functions in disc degeneration
Yanchun Tang1, Shaokun Wang1, Ying Liu1
1Department of Rheumatism and Immunity, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.
Experimental and Therapeutic Medicine
|January 8, 2014
Summary
This study identified key genes in degenerative intervertebral discs (IVDs). Matrix metalloproteinase 2 (MMP2) was upregulated, offering potential therapeutic targets for IVD degeneration.
Area of Science:
- Biochemistry
- Genomics
- Molecular Biology
Background:
- Intervertebral disc (IVD) degeneration is a significant health issue.
- Understanding the molecular mechanisms underlying IVD degeneration is crucial for developing effective treatments.
Purpose of the Study:
- To identify differentially expressed genes (DEGs) in human degenerative IVDs.
- To perform functional and interaction analyses on these DEGs.
- To identify potential therapeutic targets for IVD degeneration.
Main Methods:
- Downloaded gene expression profile (GSE34095) from the Gene Expression Omnibus database.
- Identified DEGs using R packages and performed functional analysis with WebGestalt.
- Analyzed gene interactions using Osprey and annotated the network with DAVID.
- Utilized Connectivity Map and Universal Protein database to identify small molecules and binding sites for hub genes.
Main Results:
- DEGs were significantly associated with transforming growth factor β and the extracellular matrix.
- Matrix metalloproteinase 2 (MMP2) was identified as a key hub gene in the DEG interaction network.
- MMP2 was found to be upregulated in degenerative IVDs compared to non-degenerative ones.
Conclusions:
- The identified DEGs, particularly MMP2, play a critical role in human IVD degeneration.
- Targeting MMP2 or utilizing identified small molecules may offer novel therapeutic strategies for IVD degeneration.
Related Concept Videos
01:27Degenerative Disc Disease I: Introduction
29
Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...
29
01:23Degenerative Disc Disease ll: Pathophysiology
30
The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...
30
02:34DNA Microarrays
16.8K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
16.8K